Nuralogix, a company recognized for its work in Affective AI, has introduced an upgraded version of its Anura MagicMirror.

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...

Vitamin patches offer an intriguing alternative to traditional supplements but their effectiveness remains uncertain Read ...

A 60-patient, randomized, double-blind, placebo-controlled phase I clinical study of VAS101 (topical curcumin gel) in ...

The MagicMirror is the first smart mirror that uses Nuralogix proprietary Transdermal Optical Imaging (TOITM) technology to ...

Nuralogix Corp.’s Anura Magicmirror seeks to answer questions more important than relative beauty with health insights gained via transdermal optical imaging technology and AI-powered insights into ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

Vitamin Patches Market. The global vitamin patches market is expected to grow significantly, reaching USD 10.4 billion by ...

1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China 2 Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China ...